| 10/15/25 20:12 | 10/10/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -738 | 23.72 | 0 | -31 | -17 | 154 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/2/25 16:02 | 9/30/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -702 | 22.58 | 0 | -31 | -14 | 189 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/19/25 21:17 | 9/19/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -714 | 22.95 | 0 | -31 | -12 | 223 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 9/17/24 17:21 | 9/16/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -1,341 | 36.23 | 0 | -37 | -13 | 248 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 6/21/24 19:34 | 6/21/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -1,452 | 39.24 | 0 | -37 | -11 | 302 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/20/24 17:18 | 3/19/24 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -1,068 | 57.18 | 0 | -19 | -5 | 338 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 12/5/23 16:21 | 12/1/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -1,467 | 61.14 | 0 | -24 | -6 | 347 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/21/23 16:36 | 11/17/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -445 | 49.99 | 0 | -9 | -2 | 371 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 11/21/23 16:00 | 10/17/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -1,176 | 49.00 | 0 | -24 | -6 | 380 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 4/5/23 16:54 | 4/3/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -37 | 74.05 | 0 | -1 | 0 | 404 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 3/2/23 16:20 | 3/1/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -33 | 65.33 | 0 | -1 | 0 | 404 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 2/2/23 16:15 | 2/1/23 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | S | -26 | 52.61 | 0 | -1 | 0 | 405 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |